However, our findings also suggest that there is a risk of missing patients with PVs in SMAD4 or BMPR1A if using these criteria alone: only 60% of the patients with a PV in one of these genes, who had endoscopic investigations, fulfilled the Jass criteria. The gene discussed is SMAD4; the disease is perivascular space measurement.